Respuestas clínicas Cochrane
Las Respuestas Clínicas de la Cochrane (CCA) proporcionan un punto de entrada legible, sencillo y con enfoque clínico a la investigación rigurosa de las revisiones sistemáticas de la Cochrane. Están diseñadas para ser procesables e informar sobre la toma de decisiones en el punto de atención médica y se han añadido a las secciones pertinentes del texto principal de las Best Practice.
- What are the effects of sodium glucose co‐transporter‐2 (SGLT2), dipeptidyl peptidase‐4 (DPP‐4) inhibitors and glucagon‐like peptide‐1 (GLP‐1) agonists for adults with diabetes and chronic kidney disease (CKD)?
- How does tight glycemic control compare with non-tight control for preventing diabetic kidney disease and its progression?
- In people with diabetic kidney disease, is there randomized controlled trial evidence to support the use of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists to prevent progression?
- In people with diabetic renal disease, what are the effects of protein restriction?
- What are the effects of lowered dietary salt intake for preventing diabetic kidney disease and its progression?
- In people with diabetic kidney disease, does pentoxifylline improve outcomes?
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad